pharmaceuticals-and-healthcare

2017-2022 Measles Vaccine Report on United States and Global Market, Status and Forecast, by Players, Types and Applications


Published On : Apr 2014

Category : Biotechnology

No. of Pages : 119 pages

  • $2922
  • $5944

Please click below to avail discount on this report

This report studies the Measles Vaccine on United States and global market, focuses on the top players in US market and also the market status and outlook by type and application.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Measles Vaccine in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
Asia-Pacific
South America
Middle East and Africa

The major players in United States Measles Vaccine market include Bavarian Nordic, Emergent Biosolutions, GlaxoSmithKline, Medimmune, Johnson & Johnson, CSL Limited, Merck & Co., Novartis AG, Pfizer, Sanofi

The On the basis of product, the Measles Vaccine market is primarily split into
MMR-II
Proquad

On the basis on the end users/applications, this report covers
Pediatric Vaccines
Adult Vaccines

List of Tables and Figures

Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Product Picture of Measles Vaccine
Table United States Measles Vaccine Sales (K Sets) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure United States Measles Vaccine Sales Market Share (%) by Types (Product Category) in 2016
Figure Product Picture of MMR-II
Table Major Players of MMR-II
Figure Product Picture of Proquad
Table Major Players of Proquad
Table United States Measles Vaccine Sales (K Sets) Comparison by Applications (2012-2022)
Figure United States Measles Vaccine Sales Market Share (%) by Applications in 2016
Figure Pediatric Vaccines Examples
Figure Adult Vaccines Examples
Table Global Measles Vaccine Market Size Comparison and Growth (%) by Regions (2012-2022)
Figure North America Measles Vaccine Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Asia-Pacific Measles Vaccine Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Europe Measles Vaccine Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure South America Measles Vaccine Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Middle East and Africa Measles Vaccine Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Global Measles Vaccine Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Measles Vaccine Sales (K Sets) Status and Outlook (2012-2022)
Figure United States Measles Vaccine Revenue (Million USD) Status and Outlook (2012-2022)
Figure United States Measles Vaccine Sales (K Sets) Status and Outlook (2012-2022)
Table United States Measles Vaccine Sales (K Sets) of Key Players (2012-2017)
Table United States Measles Vaccine Sales Share (%) by Players (2012-2017)
Figure 2016 United States Measles Vaccine Sales Share (%) by Players
Figure 2017 United States Measles Vaccine Sales Share (%) by Players
Table United States Measles Vaccine Revenue (Million USD) by Players (2012-2017)
Table United States Measles Vaccine Revenue Share (%) by Players (2012-2017)
Table 2016 United States Measles Vaccine Revenue Share (%) by Players
Table 2016 United States Measles Vaccine Revenue Share (%) by Players
Table United States Market Measles Vaccine Average Price (USD/Set) of Key Players (2012-2017)
Figure United States Market Measles Vaccine Average Price (USD/Set) of Key Players in 2016
Table United States Measles Vaccine Top Players Manufacturing Base Distribution and Sales Area
Table United States Measles Vaccine Top Players Product Category
Figure Measles Vaccine Market Share (%) of Top 3 Players
Figure Measles Vaccine Market Share (%) of Top 5 Players
Table Global Measles Vaccine Sales (K Sets) by Regions (2012-2017)
Figure Global Measles Vaccine Sales Market Share (%) by Regions (2012-2017)
Figure Global Measles Vaccine Sales Market Share (%) by Regions (2012-2017)
Figure 2016 Global Measles Vaccine Sales Market Share (%) by Regions
Table Global Measles Vaccine Revenue (Million USD) by Regions (2012-2017)
Table Global Measles Vaccine Revenue Market Share (%) by Regions (2012-2017)
Figure Global Measles Vaccine Revenue Market Share (%) by Regions (2012-2017)
Figure 2016 Global Measles Vaccine Revenue Market Share (%) by Regions
Table Global Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Table North America Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Table Europe Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Table Asia-Pacific Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Table South America Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Table Middle East and Africa Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Table United States Measles Vaccine Sales (K Sets) by Types (2012-2017)
Table United States Measles Vaccine Sales Share (%) by Types (2012-2017)
Figure United States Sales Measles Vaccine Market Share (%) by Types (2012-2017)
Figure United States Sales Measles Vaccine Market Share (%) by Types in 2016
Table United States Measles Vaccine Revenue (Million USD) by Types (2012-2017)
Table United States Measles Vaccine Revenue Share (%) by Types (2012-2017)
Figure United States Measles Vaccine Revenue Share (%)by Types (2012-2017)
Figure 2016 United States Measles Vaccine Revenue Market Share (%) by Types
Table United States Measles Vaccine Price (USD/Set) by Types (2012-2017)
Figure United States MMR-II Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure United States MMR-II Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure United States Proquad Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure United States Proquad Revenue (Million USD) and Growth Rate (%) (2012-2017)
Table United States Measles Vaccine Sales (K Sets) by Applications (2012-2017)
Table United States Measles Vaccine Sales Market Share (%) by Applications (2012-2017)
Figure United States Measles Vaccine Sales Market Share (%) by Applications (2012-2017)
Figure United States Measles Vaccine Sales Market Share (%) by Applications in 2016
Table United States Measles Vaccine Sales Growth Rate (%) by Applications (2012-2017)
Figure United States Measles Vaccine Sales Growth Rate (%) by Applications (2012-2017)
Figure United States Pediatric Vaccines Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure United States Adult Vaccines Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure United States Application 3 Sales (K Sets) and Growth Rate (%) (2012-2017)
Table Bavarian Nordic Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bavarian Nordic Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Bavarian Nordic Measles Vaccine Sales Growth Rate (%) (2012-2017)
Figure Bavarian Nordic Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure Bavarian Nordic Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table Emergent Biosolutions Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Emergent Biosolutions Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Emergent Biosolutions Measles Vaccine Sales Growth Rate (%) (2012-2017)
Figure Emergent Biosolutions Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure Emergent Biosolutions Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure GlaxoSmithKline Measles Vaccine Sales Growth Rate (%) (2012-2017)
Figure GlaxoSmithKline Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure GlaxoSmithKline Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table Medimmune Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Medimmune Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Medimmune Measles Vaccine Sales Growth Rate (%) (2012-2017)
Figure Medimmune Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure Medimmune Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Johnson & Johnson Measles Vaccine Sales Growth Rate (%) (2012-2017)
Figure Johnson & Johnson Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure Johnson & Johnson Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table CSL Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Limited Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure CSL Limited Measles Vaccine Sales Growth Rate (%) in United States (2012-2017)
Figure CSL Limited Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure CSL Limited Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Merck & Co. Measles Vaccine Sales Growth Rate (%) (2012-2017)
Figure Merck & Co. Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure Merck & Co. Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Novartis AG Measles Vaccine Sales Growth Rate (%) (2012-2017)
Figure Novartis AG Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure Novartis AG Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Pfizer Measles Vaccine Sales Growth Rate (%) (2012-2017)
Figure Pfizer Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure Pfizer Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Sanofi Measles Vaccine Sales Growth Rate (%) (2012-2017)
Figure Sanofi Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure Sanofi Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Measles Vaccine
Figure Measles Vaccine Industrial Chain Analysis
Table Major Buyers of Measles Vaccine
Table Distributors/Traders List
Figure Global Measles Vaccine Sales (K Sets) and Growth Rate (%) Forecast (2017-2022)
Figure Global Measles Vaccine Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
Figure United States Measles VaccineMeasles Vaccine Sales (K Sets) and Growth Rate (%) Forecast (2017-2022)
Figure United States Measles Vaccine Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
Table Global Measles Vaccine Sales (K Sets) Forecast by Regions (2017-2022)
Figure Global Measles Vaccine Sales Market Share (%) Forecast by Regions (2017-2022)
Figure North America Measles Vaccine Sales (K Sets) and Growth Rate (%) Forecast (2017-2022)
Figure North America Measles Vaccine Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Europe Measles Vaccine Sales (K Sets) and Growth Rate (%) Forecast (2017-2022)
Figure Europe Measles Vaccine Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Asia-Pacific Measles Vaccine Sales (K Sets) and Growth Rate (%) Forecast (2017-2022)
Figure Asia-Pacific Measles Vaccine Revenue and Growth Rate (%) Forecast (2017-2022)
Figure South America Measles Vaccine Sales (K Sets) and Growth Rate (%) Forecast (2017-2022)
Figure South America Measles Vaccine Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Middle East and Africa Measles Vaccine Sales (K Sets) and Growth Rate (%) Forecast (2017-2022)
Figure Middle East and Africa Measles Vaccine Revenue and Growth Rate (%) Forecast (2017-2022)
Table United Status Measles Vaccine Sales (Million USD) Forecast by Type (2017-2022)
Figure United Status Measles Vaccine Sales Market Share (%) Forecast by Type (2017-2022)
Table United Status Measles Vaccine Revenue (Million USD) Forecast by Type (2017-2022)
Figure United Status Measles Vaccine Revenue Market Share (%) Forecast by Type (2017-2022)
Table United Status Measles Vaccine Sales (K Sets) Forecast by Application (2017-2022)
Figure United Status Measles Vaccine Sales Forecast by Application (2017-2022)





  • Europe High Content Screening Market Report to 2021

    Sales, means the sales volume of High Content Screening Revenue, means the sales value of High Content Screening This report studies sales (consumption) of High Content Screening in Europe market, especially in Germany, UK, France, Russia, Italy, B...

  • Europe Viral Clearance Market Report 2016

    Sales, means the sales volume of Viral Clearance Revenue, means the sales value of Viral Clearance This report studies sales (consumption) of Viral Clearance in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, foc...

  • Japan Whole Exome Sequencing Market 2016 Industry, Analysis, Research, Share, Growth, Sales, Trends, Supply, Forecast to 2021

    The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Whole Exome Sequencing market analysis is provided for the Japan markets including development trends, competi...

  • United States Viral Clearance Market Report 2016

    Sales, means the sales volume of Viral Clearance Revenue, means the sales value of Viral Clearance This report studies sales (consumption) of Viral Clearance in United States market, focuses on the top players, with sales, price, revenue and market...

  • Europe Stem Cell Assay Market Report 2016

    Sales, means the sales volume of Stem Cell Assay Revenue, means the sales value of Stem Cell Assay This report studies sales (consumption) of Stem Cell Assay in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, foc...

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top